price

NYSE · PFE
Pfizer Inc.
Healthcare · Drug Manufacturers - General
$27.80
Down-$0.44 (-1.56%)
Updated Oct 5, 2026, 2:23 PM
SID Score
7.2/10
Composite research score
Smart Money
65/100
Neutral
- Market cap
- 146.75B
- P/E ratio
- 14.94
- Dividend yield
- 6.19%
- 52-week range
- $23.62 – $29.21
- Volume
- 35.01M
- Avg. volume
- 68.83M
Price performance · PFE
PFE price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
PFE closed at $27.80 after 19 trading sessions, up 0.04% for the selected period.
- Last close
- $27.80
- Period change
- +0.04%
- Period low
- $27.46
- Period high
- $28.72
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $28.145 | $28.16 | $27.44 | $27.80 | 35.01M |
| Oct 1, 2026 | $28.445 | $28.585 | $28.075 | $28.12 | 30.49M |
| Sep 30, 2026 | $28.79 | $28.945 | $28.52 | $28.52 | 33.64M |
| Sep 29, 2026 | $28.60 | $28.76 | $28.26 | $28.72 | 33.31M |
| Sep 28, 2026 | $28.62 | $28.87 | $28.39 | $28.72 | 24.95M |
| Sep 25, 2026 | $28.45 | $28.69 | $28.17 | $28.67 | 27.76M |
| Sep 24, 2026 | $28.20 | $28.85 | $28.20 | $28.41 | 34.77M |
| Sep 23, 2026 | $27.96 | $28.23 | $27.84 | $28.18 | 33.81M |
| Sep 22, 2026 | $27.74 | $28.00 | $27.49 | $27.93 | 26.67M |
| Sep 21, 2026 | $27.65 | $27.92 | $27.53 | $27.74 | 28.78M |
| Sep 18, 2026 | $27.64 | $27.66 | $27.34 | $27.66 | 75.59M |
| Sep 17, 2026 | $27.62 | $27.81 | $27.55 | $27.64 | 29.01M |
| Sep 16, 2026 | $27.64 | $27.69 | $27.36 | $27.46 | 26.05M |
| Sep 15, 2026 | $27.615 | $27.66 | $27.245 | $27.55 | 40.44M |
| Sep 14, 2026 | $28.08 | $28.19 | $27.685 | $27.72 | 28.57M |
| Sep 11, 2026 | $27.80 | $27.85 | $27.42 | $27.72 | 25.56M |
| Sep 10, 2026 | $27.69 | $27.75 | $27.40 | $27.65 | 28.81M |
| Sep 9, 2026 | $27.76 | $27.975 | $27.57 | $27.78 | 29.14M |
| Sep 8, 2026 | $28.015 | $28.145 | $27.715 | $27.79 | 31.77M |
Latest PFE news
The latest Smart Investors Daily articles mentioning PFE.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

